IMV Technologies in the news

Frank Gaillard discusses his career shift to LBO and interim management, highlighting clear objectives and a music-influenced management style.

Bovintel Fertility, an AI-based imaging diagnostic tool for bovine reproduction by IMV Technologies, won a top award at the 2025 Sommet de l’élevage.

Frank Gaillard leads finance transformation at IMV Technologies, enhancing processes and forecasting while fostering collaboration and exploring AI integration.

Bric €levages app helps estimate livestock building costs regionally, while IMV Technologies enhances bovine reproduction diagnostics with AI-assisted ultrasound imaging.

IMV Technologies, a global leader in animal reproduction biotechnologies, remains committed to its L'Aigle site, emphasizing innovation and international growth.

IMV Technologies exports 400 million artificial insemination straws annually from Orne to 130 countries, showcasing its manufacturing process.

IMV Technologies exports 400 million artificial insemination straws annually from Orne to 130 countries, showcasing its production process.

Oliver Kohlhaas succeeds Alain de Lambilly as CEO of IMV Technologies Group, aiming to continue growth and strategic development.

Oliver Kohlhaas will succeed Alain de Lambilly as President of IMV Technologies' Executive Board on April 1, 2025, bringing extensive experience from Bayer to continue the company's growth and strategy.

Oliver Kohlhaas will become Chairman of IMV Technologies in April 2025, succeeding Alain de Lambilly who is stepping down for family reasons after leading significant company growth.

Oliver Kohlhaas will become CEO of IMV Technologies in April 2025, succeeding Alain de Lambilly who led the company's growth and transformation.

Conception Ro-Main Inc. will join IMV Technologies' Farm Animal business, expanding its high-tech solutions for sustainable swine production globally.

IMV Technologies acquired UD-Vet to strengthen its veterinary imaging and equipment presence in the Benelux region.

IMV Technologies introduced BovIntel software to improve bovine fertility scanning accuracy and vet breeding advice, boosting dairy productivity.

BioVaxys acquired IMV's intellectual property and clinical assets, expanding its immunotherapy pipeline and platform technologies for oncology and infectious diseases.

BioVaxys acquired IMV's DPX platform and cancer vaccine assets, expanding its immunotherapy pipeline and development potential.

BioVaxys acquired bankrupt IMV's cancer vaccine and other biotech assets, including MVP-S, with trials paused due to IMV's bankruptcy.

IMV Technologies is undertaking a leveraged buyout, with detailed coverage behind a subscription paywall.

BCF Technology and ECM merged to form IMV imaging under IMV Technologies, expanding their animal reproduction imaging portfolio globally.

IMV Technologies has integrated BCF Technology to expand its veterinary imaging and reproduction management solutions globally.